1. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway
   XIANGLIANG ZHANG et al, 2015, International Journal of Molecular Medicine CrossRef
2. Systemic explanation of Glycyrrhiza glabra's analyzed compounds and anti-cancer mechanism based on network pharmacology in oral cancer
   Vaibhav S. Ladke et al, 2022, Journal of Oral Biosciences CrossRef
3. LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma
   Libin Wang et al, 2018, Cancer Biomarkers CrossRef
4. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor
   Komala Ingle et al, 2023, PLOS ONE CrossRef
5. Effects of Different Ratio of n-6/n-3 Polyunsaturated Fatty Acids on the PI3K/Akt Pathway in Rats with Reflux Esophagitis
   Jia-Yuan Zhuang et al, 2017, Medical Science Monitor CrossRef
6. (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells
   Panpan Wu et al, 2020, Bioorganic Chemistry CrossRef
7. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells
   Yufeng Wang et al, 2017, International Journal of Oncology CrossRef
8. Development of novel PET probes targeting phosphatidylinositol 3-kinase (PI3K) in tumors
   Akira Makino et al, 2016, Nuclear Medicine and Biology CrossRef
9. RETRACTED: miR-149 regulates the proliferation and apoptosis of cervical cancer cells by targeting GIT1
   Bing Qian et al, 2018, Biomedicine & Pharmacotherapy CrossRef